Kurzübersicht für ApoScreen® Annexin V Apoptosis Kit-FITC (ABIN376221)
Target
Alle Annexin V (ANXA5) Kits anzeigenApplikation
-
-
Konjugat
- FITC
-
Verwendungszweck
- ApoScreen® Annexin V Apoptosis Kit-FITC
-
Produktmerkmale
- FITC ApoScreen® Annexin V Apoptosis Kit for use in flow cytometry and immunocytochemistry assays.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
E.coli expressed Annexin V
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Annexin V-FITC - Annexin V Binding Buffer PI - Annexin V Binding Buffer Annexin V Binding Buffer - Contains 0.1 % sodium azide and proprietary ingredients
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
-
Protect conjugated products from light.
Each reagent is stable for the period shown on the bottle label if stored as directed. -
Lagerung
- 4 °C
-
Informationen zur Lagerung
- 2-8°C
-
-
-
: "Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death." in: Oncotarget, Vol. 6, Issue 33, pp. 34573-91, (2016) (PubMed).
: "8-Amino-adenosine activates p53-independent cell death of metastatic breast cancers." in: Molecular cancer therapeutics, Vol. 11, Issue 11, pp. 2495-504, (2012) (PubMed).
: "Inhibition effect of siRNA-downregulated UHRF1 on breast cancer growth." in: Cancer biotherapy & radiopharmaceuticals, Vol. 26, Issue 2, pp. 183-9, (2011) (PubMed).
-
-
- Annexin V (ANXA5) (Annexin A5 (ANXA5))
-
Andere Bezeichnung
- Annexin V
-
Hintergrund
- Optional[Description]: ApoScreen® Annexin V Apoptosis Kit-FITC
Target
-